Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...

On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...

Cellarity has published a manuscript in Science describing its framework to integrate advanced transcriptomics and AI models for drug discovery.

SPT Labtech, and 10x Genomics, Inc. (Nasdaq: TXG), announced a strategic partnership to provide automated workflows for ...

One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and ...

Researchers have identified a rare type of brain cell whose overactivity may contribute to schizophrenia-like symptoms, such as cognitive deficits and disrupted sleep.

The human body has good reason for its tighter controls. Cells that multiply unchecked are the roots of cancer. “Our hope is ...

This is an area Laith from Peak Physio is particularly passionate about, explaining that he was intrigued by a research study ...